Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series A
Biotech
Kailera launches with $400M series A, 4 Chinese obesity drugs
Kailera has launched into the increasingly crowded obesity space with a portfolio of assets acquired from China and $400 million in series A funds.
James Waldron
Oct 1, 2024 8:30am
Lilly-backed Superluminal speeds toward the clinic with $120M
Sep 9, 2024 7:00am
Navigator raises $100M to develop new autoimmune pipeline
Aug 27, 2024 8:50am
Novartis, Versant hope to repeat Chinook’s success with Borealis
Aug 22, 2024 8:00am
J&J vets burst into biotech with $165M Third Arc series A
Jul 23, 2024 10:00am
VC firm that took NGM private oversees biotech’s $122M series A
Jul 17, 2024 7:42am